FDA Recalls PGE1-Lidocaine Injectable Due to Insanitary Compounding Conditions
Professional Compounding Pharmacy is recalling PGE1-Lidocaine injectable products because FDA inspectors observed insanitary conditions during the compounding of sterile drugs.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the source text explicitly states that no illnesses or injuries have been reported, which aligns with the rubric for a High severity score (risk-of-harm products where injury has not yet been reported).
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE products manufactured by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy. The recall involves 25 prescriptions of 10 ml and 9 ml injectable vials. These products were dispensed in Oregon between September 1, 2018, and February 20, 2019.
The recall was initiated due to a lack of processing controls. Specifically, FDA inspectors observed insanitary conditions during the compounding of sterile drugs during a recent inspection. This classification indicates that the use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Patients who have received these specific prescriptions should contact their healthcare provider or the pharmacy for further instructions. The FDA has not reported any illnesses or injuries associated with this recall.
The recalled product
- Product
- PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE, (a) 10 ml (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot:(a) 26092018@22
- 26092018@22
- 09102018@47
- 15102018@33
- 29112018@4
- 10122018@14
- 19122018@20
- 21122018@29
- 27122018@20
- (b) 16012019@59
- 18012019@17
- 21012019@49
- 22012019@24
- distributed between 09-01-2018 to 02-20-2019.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 25 recalled by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
See all →- SevereFDA Recalls Compounded Sodium Chloride Eye Drops Due to Insanitary Conditions
FDA (Drugs) · 2019-04-17
- SevereFDA Recalls Compounded Papaverine-Phentolamine-PGE1 Injectable Due to Insanitary Conditions
FDA (Drugs) · 2019-04-17
- SevereFDA Recalls Compounded Injectable Drug Due to Insanitary Compounding Conditions
FDA (Drugs) · 2019-04-17
- Severe
- Severe
Same hazard · contamination
See all →- HighMedline Recalls Gynecologic Robotic Surgery Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls Surgical Convenience Kits Due to Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 419 Surgical Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02
- HighMedline C-Section Convenience Kits Recalled for Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 71 Convenience Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02